Reduced Klotho is associated with the presence and severity of coronary artery disease - PubMed (original) (raw)

Comparative Study

Reduced Klotho is associated with the presence and severity of coronary artery disease

Juan F Navarro-González et al. Heart. 2014 Jan.

Abstract

Objective: Klotho is involved in vascular health. We aimed to analyse in a cross-sectional study the relationship between Klotho and human coronary artery disease (CAD).

Methods: The study included 371 subjects who underwent coronary angiography and 70 patients who underwent elective cardiac surgery recruited between May 2008 and June 2009. The presence and severity (stenosis index) of CAD, cardiovascular risk factors, Klotho gene expression in the thoracic aorta, and serum soluble Klotho concentrations were evaluated.

Results: The soluble Klotho concentration was lower (p<0.001) in patients with significant CAD (n=233). The maximal stenosis observed in every epicardial artery and the stenosis severity index was significantly lower in patients within the higher soluble Klotho concentrations (p<0.0001). Multiple regression analysis showed that serum Klotho concentrations were inverse and significantly associated with CAD (adjusted R(2)=0.67, p<0.001). Multivariate logistic regression analysis showed that risk factors for significant CAD included age, diabetes, smoking and inflammation, whereas high serum Klotho values were associated with a lower risk for CAD. Lower mRNA expression level of Klotho was observed in 46 patients with significant CAD, as compared with subjects without CAD (p=0.01). Logistic regression analysis showed that high Klotho gene expression was independently associated with lower risk for CAD.

Conclusions: Patients with significant CAD present lower soluble concentrations of Klotho, as well as reduced levels of Klotho gene expression in the vascular wall. Reduced serum Klotho concentrations and decreased vascular Klotho gene expression were associated with the presence and severity of CAD independently of established cardiovascular risk factors.

Keywords: Coronary Artery Disease.

PubMed Disclaimer

Cited by

Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability.
Vila Cuenca M, Ferrantelli E, Meinster E, Pouw SM, Kovačević I, de Menezes RX, Niessen HW, Beelen RHJ, Hordijk PL, Vervloet MG. Vila Cuenca M, et al. J Am Heart Assoc. 2018 Sep 4;7(17):e008776. doi: 10.1161/JAHA.118.008776. J Am Heart Assoc. 2018. PMID: 30371149 Free PMC article.
Circulating α-Klotho Levels in Relation to Cardiovascular Diseases: A Mendelian Randomization Study.
Sun X, Chen L, He Y, Zheng L. Sun X, et al. Front Endocrinol (Lausanne). 2022 Feb 7;13:842846. doi: 10.3389/fendo.2022.842846. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35197934 Free PMC article.
Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.
Ozeki M, Fujita S, Kizawa S, Morita H, Sohmiya K, Hoshiga M, Ishizaka N. Ozeki M, et al. BMC Nephrol. 2014 Sep 8;15:147. doi: 10.1186/1471-2369-15-147. BMC Nephrol. 2014. PMID: 25200959 Free PMC article.
Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients.
Buiten MS, de Bie MK, Bouma-de Krijger A, van Dam B, Dekker FW, Jukema JW, Rabelink TJ, Rotmans JI. Buiten MS, et al. BMC Nephrol. 2014 Dec 11;15:197. doi: 10.1186/1471-2369-15-197. BMC Nephrol. 2014. PMID: 25495997 Free PMC article.
Patients With Coronary Microvascular Dysfunction Have Less Circulating α-Klotho.
Akhiyat N, Ozcan I, Gulati R, Prasad A, Tchkonia T, Kirkland JL, Lewis B, Lerman LO, Lerman A. Akhiyat N, et al. J Am Heart Assoc. 2024 May 7;13(9):e031972. doi: 10.1161/JAHA.123.031972. Epub 2024 Apr 19. J Am Heart Assoc. 2024. PMID: 38639380 Free PMC article.

Reduced Klotho is associated with the presence and severity of coronary artery disease - PubMed (original) (raw)